Skip to main content

Treatment Clinical Trials for Breast Cancer

Review the breast cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 426-450 of 478

Combined Immunotherapies in Metastatic ER+ Breast Cancer
Status: Active
Location: UPMC Hillman Cancer Center Erie, Erie, Pennsylvania
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Status: Active
Location: See ClinicalTrials.gov
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
Status: Active
Location: See ClinicalTrials.gov
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Status: Active
Location: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas
A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
Status: Active
Location: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Status: Active
Location: See ClinicalTrials.gov
Evaluation of AP-002 in Patients With Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Status: Active
Location: See ClinicalTrials.gov
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
Status: Active
Location: See ClinicalTrials.gov
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
Status: Active
Location: See ClinicalTrials.gov
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Status: Active
Location: 3 locations
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study of BND-35 in Participants With Advanced Solid Tumors
Status: Active
Location: University of Colorado, Denver, Colorado
A Study of DF6002 Alone and in Combination With Nivolumab
Status: Active
Location: See ClinicalTrials.gov
Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology
Status: Active
Location: See ClinicalTrials.gov
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
Status: Active
Location: See ClinicalTrials.gov
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.
Status: Active
Location: See ClinicalTrials.gov
Time Restricted Eating During Chemotherapy for Breast Cancer
Status: Active
Location: See ClinicalTrials.gov